Glenmark Q3 results: Company reports net loss of Rs 351 crore on lower domestic sales
Total revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a statement. The lower sales in the current quarter are mainly on account of a one-time impact on the company's India business, it added.
The Mumbai-based drug maker had posted a net profit of Rs 272 crore in the October-December quarter of previous fiscal. Image Courtesy: Reuters.